January 12-15, 2026 | San Francisco Marriott Marquis, CA
Prothena is a clinical-stage biotechnology company with expertise in protein dysregulation and a diverse pipeline of novel investigational therapies for neurodegenerative and rare peripheral amyloid diseases.